Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01198184 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00415324 | Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00606437 | Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants | completed | Phase 1 | 40 | Duke UniversityOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT01957280 | Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287) | completed | Phase 1 | 17 | Daiichi SankyoINDUSTRY | 1 | May 14, 2014 | clinicaltrials |
| NCT01240538 | Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 26 | National Cancer Institute (NCI)NIH | 2 | May 13, 2014 | clinicaltrials |
| NCT00607880 | Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy | completed | Phase 2 | 100 | Mayo ClinicOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00147225 | AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | completed | Phase 1 / Phase 2 | 55 | M.D. Anderson Cancer CenterOTHER | 1 | May 8, 2014 | clinicaltrials |
| NCT00008424 | Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants | completed | Phase 1 | 7 | Children's Oncology GroupNETWORK | 3 | May 5, 2014 | clinicaltrials |
| NCT00880282 | Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT01231919 | MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT02046850 | To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers | completed | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Apr 29, 2014 | clinicaltrials |
| NCT00002923 | KRN5500 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00028548 | XK469 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00004144 | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT01235897 | MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies | completed | Phase 1 | 17 | University of California, San FranciscoOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | completed | Phase 1 | 31 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 11, 2014 | clinicaltrials |
| NCT00786838 | A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram | completed | Phase 2 | 76 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 7 | Apr 11, 2014 | clinicaltrials |
| NCT01141244 | Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 72 | National Cancer Institute (NCI)NIH | 2 | Apr 10, 2014 | clinicaltrials |
| NCT00112996 | Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 244 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT01725555 | A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors | completed | Phase 1 | 13 | Axelar ABINDUSTRY | 1 | Apr 7, 2014 | clinicaltrials |
| NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01096355 | Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01243359 | Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | completed | Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00884845 | Trial of PM02734 Administered in Combination With Erlotinib in Patients With Advanced Malignant Solid Tumors | completed | Phase 1 | 35 | PharmaMarINDUSTRY | 2 | Mar 26, 2014 | clinicaltrials |
| NCT01184807 | Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors | completed | Phase 1 | 51 | Otsuka Beijing Research InstituteINDUSTRY | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00125827 | Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors | completed | Phase 1 | 24 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00942799 | Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors | completed | Phase 1 | 87 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00890747 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2014 | clinicaltrials |
| NCT00477607 | Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin | completed | Phase 2 / Phase 3 | 39 | US Department of Veterans AffairsFED | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00003766 | O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery | completed | Phase 1 | 25 | University of ChicagoOTHER | 1 | Mar 6, 2014 | clinicaltrials |
| NCT01455571 | Phase I Study to Determine the Maximum Tolerated Dose and to Assess the Safety and Pharmacokinetic Profile of HM781-36B in Patients With Advanced Solid Tumors | completed | Phase 1 | 55 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Feb 26, 2014 | clinicaltrials |
| NCT01058538 | A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours | completed | Phase 1 / Phase 2 | 33 | Philogen S.p.A.INDUSTRY | 2 | Feb 25, 2014 | clinicaltrials |
| NCT01364844 | Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors | completed | Phase 1 | 42 | Daiichi SankyoINDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00046917 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00121290 | SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00227513 | Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00324480 | Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00348699 | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00357318 | Bevacizumab and Sunitinib in Treating Patients With Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00462553 | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00499811 | Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00622414 | Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01145456 | Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00006095 | Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | 20 | Children's Oncology GroupNETWORK | 2 | Feb 21, 2014 | clinicaltrials |
| NCT00006463 | Ecteinascidin 743 in Treating Children With Refractory Solid Tumors | completed | Phase 1 | 13 | Children's Oncology GroupNETWORK | 3 | Feb 21, 2014 | clinicaltrials |
| NCT00070473 | Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors | completed | Phase 1 | 33 | Children's Oncology GroupNETWORK | 2 | Feb 20, 2014 | clinicaltrials |
| NCT01012102 | EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors | completed | Phase 1 | 104 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 0 | Feb 20, 2014 | clinicaltrials |
| NCT00458731 | Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma | completed | Phase 1 | 57 | National Cancer Institute (NCI)NIH | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00002485 | Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer | completed | — | 359 | Children's Oncology GroupNETWORK | 4 | Feb 14, 2014 | clinicaltrials |
Data updated 23 days agoSource updated May 30, 2014source: clinicaltrials